|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01N 37/18 | |
| A61K 31/165 | |||
| C07C 233/60 | |||
| C07C 271/44 | |||
| C07F 9/12 |
| (11) | Patento numeris | 2405751 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10751489.5 |
| Europos patento paraiškos padavimo data | 2010-03-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-01-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-08-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/027177 |
| Data | 2010-03-12 |
| (87) | Numeris | WO 2010/105183 |
| Data | 2010-09-16 |
| (30) | Numeris | Data | Šalis |
| 159723 P | 2009-03-12 | US |
| (72) |
SMITH, Charles, D., US
ZHUANG, Yan, US
MAINES, Lynn, W., US
|
| (73) |
Apogee Biotechnology Corporation,
1214 Research Blvd., Suite 1016 Hershey Center For Applied Research, Hummelstown, PA 17036,
US
|
| (54) | SPHINGOSINE KINASE INHIBITOR PRODRUGS |
| SPHINGOSINE KINASE INHIBITOR PRODRUGS |